<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00388856</url>
  </required_header>
  <id_info>
    <org_study_id>17791137</org_study_id>
    <nct_id>NCT00388856</nct_id>
  </id_info>
  <brief_title>Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status</brief_title>
  <official_title>Vitamin C and E Supplementation in Pregnant Women With Low Antioxidant Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Showa University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Showa University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate antioxidants supplementation in pregnant women&#xD;
      with low antioxidant status at 10-12 weeks gestation age in relation to adverse pregnancy&#xD;
      outcome in randomized prospective study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preeclampsia still remains a leading cause of feto-maternal mortality and morbidity in&#xD;
      developed and developing world. Despite of intensive research, the underlying pathologic&#xD;
      mechanisms of this disease remain elusive. It has been agreed that incomplete or absent&#xD;
      transformation of spiral arteries by replacing endothelial cells and mural vascular smooth&#xD;
      muscle cells has been observed in the placental bed of preeclamptic patients and severe cases&#xD;
      of intrauterine growth restriction. Oxidative stress has been proposed as a link between&#xD;
      these mechanisms. However, it has been demonstrated by two large studies that antioxidant&#xD;
      supplementation does not reduce the risk of preeclampsia. Our initial study has been shown&#xD;
      that antioxidant supplementation may be reduce the risk of preeclampsia in pregnant women&#xD;
      with low antioxidant status.&#xD;
&#xD;
      Comparison(s): adverse pregnancy outcome between vitamin C and E given and placebo given to&#xD;
      pregnant women with low antioxidant status at 10-12 weeks gestation age&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>preeclampsia cases</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse pregnancy outcome</measure>
  </secondary_outcome>
  <enrollment type="Actual">400</enrollment>
  <condition>Preeclampsia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C 1000mg and E 400IU</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Agree to consent form, and consent to protocol of research&#xD;
&#xD;
          -  Known healthy singleton 6-10 weeks pregnant women&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Blood pressure &gt; 135/85&#xD;
&#xD;
          -  Proteinuria&#xD;
&#xD;
          -  History or current use of anti-hypertensive medication or diuretics&#xD;
&#xD;
          -  Use of vitamins C &gt; 150 mg and/or E &gt; 75 IU per day&#xD;
&#xD;
          -  Pregestational diabetes&#xD;
&#xD;
          -  Known placental abnormalities.&#xD;
&#xD;
          -  Current pregnancy is a result of in vitro fertilization&#xD;
&#xD;
          -  Regular use of platelet active drugs or non-steroidal anti-inflammatory drugs&#xD;
&#xD;
          -  Known fetal abnormalities&#xD;
&#xD;
          -  Documented uterine bleeding within a week of screening&#xD;
&#xD;
          -  Uterine malformations&#xD;
&#xD;
          -  History of medical complications&#xD;
&#xD;
          -  Illicit drug or alcohol abuse during current pregnancy&#xD;
&#xD;
          -  Intent to deliver elsewhere&#xD;
&#xD;
          -  Known psychologic problems.&#xD;
&#xD;
          -  Participating in another interventional study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Akihiko Sekizawa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Showa University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cipto Mangunkusumo National Hospital</name>
      <address>
        <city>Jakarta</city>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>October 16, 2006</study_first_submitted>
  <study_first_submitted_qc>October 16, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2006</study_first_posted>
  <last_update_submitted>February 16, 2010</last_update_submitted>
  <last_update_submitted_qc>February 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Yuditiya Purwosunu</name_title>
    <organization>Univ. Indonesia</organization>
  </responsible_party>
  <keyword>antioxidant supplementation</keyword>
  <keyword>preeclampsia</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

